Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes (Q51375055)

4 April 2018

title

Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes (English)

1 reference

4 April 2018

0 references

1 reference

Alev E Altinova

1

1 reference

4 April 2018

Fusun Toruner

2

1 reference

4 April 2018

Mujde Akturk

3

1 reference

4 April 2018

Neslihan Bukan

4

1 reference

4 April 2018

Ilhan Yetkin

5

1 reference

4 April 2018

Nuri Cakir

6

1 reference

4 April 2018

Metin Arslan

7

1 reference

4 April 2018

publication date

12 April 2011

1 reference

4 April 2018

Scandinavian Journal of Clinical and Laboratory Investigation

published in

1 reference

4 April 2018

volume

71

1 reference

4 April 2018

issue

4

1 reference

4 April 2018

page(s)

340-343

1 reference

4 April 2018

RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

Osteoprotegerin, vascular calcification and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

The relationship between coronary artery calcification score, plasma osteoprotegerin level and arterial stiffness in asymptomatic type 2 DM.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

Association between plasma osteoprotegerin concentrations and urinary albumin excretion in Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

Osteoprotegerin (OPG) and receptor activator of NF-kB ligand (RANK-L) serum levels in patients on chronic hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

Relation between serum osteoprotegerin and carotid intima media thickness in a general population – the Tromsø Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2011.570868

10.3109/00365513.2011.570868

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018